Immucell (ICCC) Enterprise Value (2016 - 2025)
Immucell (ICCC) has disclosed Enterprise Value for 16 consecutive years, with -$3.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value fell 2.04% year-over-year to -$3.9 million, compared with a TTM value of -$3.9 million through Sep 2025, down 2.04%, and an annual FY2024 reading of -$3.8 million, down 283.99% over the prior year.
- Enterprise Value was -$3.9 million for Q3 2025 at Immucell, up from -$6.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$960347.0 in Q1 2024 and bottomed at -$11.8 million in Q1 2022.
- Average Enterprise Value over 5 years is -$5.4 million, with a median of -$4.2 million recorded in 2025.
- The sharpest move saw Enterprise Value surged 86.83% in 2023, then plummeted 378.93% in 2025.
- Year by year, Enterprise Value stood at -$10.2 million in 2021, then soared by 43.14% to -$5.8 million in 2022, then surged by 83.1% to -$978741.0 in 2023, then plummeted by 283.99% to -$3.8 million in 2024, then decreased by 3.4% to -$3.9 million in 2025.
- Business Quant data shows Enterprise Value for ICCC at -$3.9 million in Q3 2025, -$6.0 million in Q2 2025, and -$4.6 million in Q1 2025.